At Cipla, we constantly work towards ensuring access to high quality and affordable medicines to support patients in need. Which is why, we have been trusted by health care professionals and patients across geographies for the last 9 decades.
Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 74 markets providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.
For over nine decades, making a difference to patients has inspired every aspect of Cipla’s work. Our paradigm-changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of Caring for Life and deep-rooted community links wherever it is present, make it a partner of choice for global health bodies and stakeholders.
Quick Facts
Founder (1898-1972)
Dr. K.A. Hamied
Non-Executive Chairman
Dr. Y.K. Hamied
Incorporated
1935
Employees
30,000+
Turnover
$ 3.26 Billion
Registered Office
Cipla Ltd.
Cipla House, Peninsula Business Park,
Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
CIN: L24239MH1935PLC002380
Listing
Equity Shares: BSE Limited and National Stock Exchange of India Limited
Global Depository Receipts: Luxembourg Stock Exchange
"Our work is not just making medicines. It is about making a difference."
Dr. Y K Hamied | Non-Executive Chairman
CREDO
Our core values guide every conversation, organizational decision and anchor the actions of our employees. We consistently revisit them and recalibrate strategies to stay ever-relevant to our stakeholders...... read more about Cipla credo
We are a
-
Purpose - Inspired
-
Responsibility - Centered
-
Innovation - Driven
-
Integrity & Trust - Anchored
-
Excellence - Focused
global pharmaceutical firm that consistently Cares for Life and delivers on its commitment to all our stakeholders- patients, regulators, customers, partners, employees, investors and community.
Manufacturing highlights
Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.
30.54 Billion Units
Tablets and Capsules
773.60 Million Units
Respules
51.60 Million Units
Oral Liquids
48 Million Units
Nasal Sprays
125.80 Million Units
Aerosol pMDI
1.63 Million Units
Lyophilised Injections
2.50 Million Units
Form Fill Seal Eye Drops
46 Million Units
Pre-Filled Syringes
Our History–Cipla Archives
The Cipla story is one of purpose and perseverance, built on the foundation of care. Explore the milestones of Cipla's illustrious legacy of care!
Read More about Cipla archiveA tribute to Dr. Y.K. Hamied
Celebrating the living legend–Pharmaceutical scientist and philanthropist, Dr. Y.K. Hamied!
Read More about Dr. Y. K. Hamied